MHIC
CRDL
Marble Harbor Investment Counsel’s Cardiol Therapeutics CRDL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.3K | Buy |
39,900
+3,000
| +8% | +$4.08K | 0.01% | 202 |
|
|
2025
Q1 | $35.8K | Hold |
36,900
| – | – | ﹤0.01% | 205 |
|
|
2024
Q4 | $47.2K | Hold |
36,900
| – | – | 0.01% | 205 |
|
|
2024
Q3 | $73.1K | Hold |
36,900
| – | – | 0.01% | 209 |
|
|
2024
Q2 | $74.5K | Hold |
36,900
| – | – | 0.01% | 203 |
|
|
2024
Q1 | $66.8K | Hold |
36,900
| – | – | 0.01% | 203 |
|
|
2023
Q4 | $31.1K | Hold |
36,900
| – | – | ﹤0.01% | 197 |
|
|
2023
Q3 | $33K | Hold |
36,900
| – | – | ﹤0.01% | 188 |
|
|
2023
Q2 | $32.8K | Hold |
36,900
| – | – | ﹤0.01% | 187 |
|
|
2023
Q1 | $18K | Hold |
36,900
| – | – | ﹤0.01% | 189 |
|
|
2022
Q4 | $18.8K | Hold |
36,900
| – | – | ﹤0.01% | 184 |
|
|
2022
Q3 | $38K | Sell |
36,900
-1,250
| -3% | -$1.29K | 0.01% | 172 |
|
|
2022
Q2 | $50K | Buy |
38,150
+9,250
| +32% | +$12.1K | 0.01% | 180 |
|
|
2022
Q1 | $44K | Buy |
28,900
+6,000
| +26% | +$9.14K | 0.01% | 189 |
|
|
2021
Q4 | $42K | Buy |
22,900
+900
| +4% | +$1.65K | ﹤0.01% | 195 |
|
|
2021
Q3 | $91K | Buy |
+22,000
| New | +$91K | 0.01% | 189 |
|